Answers are grounded in this paper and cite their sources.
In two national randomized clinical trials using contemporary adjuvant chemotherapy, we confirm that stromal lymphocytic infiltration constitutes a robust prognostic factor in TNBCs. Studies assessing outcomes and therapeutic efficacies should consider stratification for this parameter.
No takes yet. Share an insight, caveat, or question.
Adams et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: